Expert InsightsA high-throughput test for neutralizing antibodies to SARS-CoV-2 as alternative to live virus neutralization and immunoglobulin detection
Industry NewsAvacta provides update on COVID-19 rapid antigen test development partnership with Cytiva
Editorial ArticleNitrosamine impurities: How LGC experts are protecting public health against carcinogens